Effect of Dextrose injection in treatment of Chronic Plantar Fasciitis
- Conditions
- Plantar Fasciitis.Plantar fascial fibromatosisM72.2
- Registration Number
- IRCT20200223046590N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 38
Patient's age 18 to 65 years
Point Tenderness at the Medial Calcaneal Tubercle
Heel pain with the first step in the morning or after prolonged standing
Thickness of plantar fascia greater than 4 mm in ultrasound
Resistant to supportive treatments for at least three months
Diabetes Mellitus
Peripheral Neuropathy
History of lower extremity radicular pain in L5 and S1 spinal segments
Coagulation Disorders
Vasculitis and Other Vascular Diseases
Tarsal Tunnel Syndrome
Instability of foot and ankle joints
Foot and Ankle joints Arthritis
Evidence of cancer
Acute infection
Skin diseases
History of foot and ankle surgery
History of foot and ankle fractures
Corticosteroid injection in the last 6 weeks
Bilateral Plantar Fasciitis
Systemic Inflammatory Diseases
Pregnancy
Receive shockwave therapy or injectable plantar fasciitis treatment in the last 6 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of morning and daily pain. Timepoint: ??? ?? ????? ? ?????? ????? ? 1 ??? ? 3 ??? ?? ?? ????? ? ?????? ?????. Method of measurement: Visual Analog Scale (VAS).;Evaluation of foot and ankle function. Timepoint: Before injection and shock-wave therapy , 1 month and 3 months after injection and shock-wave therapy. Method of measurement: Foot and Ankle Ability Measure (FAAM).;Thickness of plantar fascia. Timepoint: Before injection and shock-wave therapy , 1 month and 3 months after injection and shock-wave therapy. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method